RUNX1 anticorps (N-Term)
Aperçu rapide pour RUNX1 anticorps (N-Term) (ABIN207336)
Antigène
Voir toutes RUNX1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Synthetic peptide corresponding to N-terminal residues of human RUNX1(Runt-related transcription factor 1)
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human RUNX1.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))
-
Autre désignation
- AML1 / RUNX1
-
Sujet
-
Name/Gene ID: RUNX1
Synonyms: RUNX1, AMLCR1, Aml1 oncogene, AML1, AML1-EVI-1, CBF-alpha-2, CBFA2, Acute myeloid leukemia 1, EVI-1, PEBP2A2, PEA2-alpha B, AML1-EVI-1 fusion protein, Oncogene AML-1, PEBP2-alpha B, PEBP2aB -
ID gène
- 861
-
UniProt
- Q01196
Antigène
-